4//SEC Filing
ELAN PHARMACEUTICAL INVESTMENTS LTD 4
Accession 0000950162-04-000520
CIK 0000810084other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:31 PM ET
Size
11.5 KB
Accession
0000950162-04-000520
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-16$3.00/sh−5,000$15,000→ 2,429,936 total(indirect: I) - Sale
Common Stock
2004-04-15$3.07/sh−5,000$15,350→ 2,434,936 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001279105
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:31 PM ET
- Size
- 11.5 KB